CPRTNEUTRAL

CPRT Revenue Growth (YoY) Analysis

2.1%

Updated 153h ago·SEC filings & market data

Key Takeaway

CPRT's revenue growth (YoY) of 2.1% means sales increased by 2.1% versus the same quarter last year.

Sector Performance

20th percentile

CPRT

2.1%

Sector Median

9.0%

Sector Avg

14.8%

Prior Period

-3.6%(Apr 2026)

↑ Improving

📊

Deep Analysis

CPRT's revenue growth (YoY) of 2.1% means sales increased by 2.1% versus the same quarter last year.

This sits below the sector median of 8.7%, placing the company at the 21st percentile among peers. The metric's trend is unavailable: the year-over-year change is N/A and the quarter-over-quarter change is N/A, with only a single historical value of 2.1%. The low growth level relative to peers, combined with no trend information, leaves limited evidence for future direction, creating an uncertain risk profile. This uncertainty is consistent with a NEUTRAL verdict, as the current metric neither strongly supports nor contradicts it. Thus, the growth figure alone does not shift the overall stance.

Frequently Asked Questions

What does the Revenue Growth (YoY) tell investors about CPRT?

Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.

How is the Revenue Growth (YoY) calculated?

Revenue Growth (YoY) is calculated as: (Revenue_t - Revenue_t-4) / Revenue_t-4.

Who are CPRT's closest peers by Revenue Growth (YoY)?

The closest peers by Revenue Growth (YoY) include: TMUS (7.9%), MCK (7.7%), SIEGY (7.3%), CB (7.2%), MHK (6.8%).

📚

Learn More About Revenue Growth (YoY)

How to Analyze Revenue Growth: More Than Just Rising Sales

Learn how to analyze revenue growth beyond the headline number. Master absolute vs percentage, YoY vs QoQ, and sustainable growth with real examples from NVDA, GOOGL, and MDB.

The Formula

(Revenue_t - Revenue_t-4) / Revenue_t-4

Why It Matters

Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.